Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogenetics

Indian Journal of Human Genetics

Volumn 17, Issue SUPPL. 1, 2011, Pages

  Grover, Sandeep ^a   Gupta, Meenal ^a   Kukreti, Ritushree ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Epilepsy; pharmacogenomics; phenotype; sample size; study design

Indexed keywords

ANTICONVULSIVE AGENT;

BIOINFORMATICS; DRUG RESPONSE; EPILEPSY; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC HETEROGENEITY; HUMAN; INDIA; PHARMACOGENETICS; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79956076488     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.80351     Document Type: Review

References (25)

1. Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 2009;50:1-23.
2. Tan NC, Mulley JC, Berkovic SF. Genetic association studies in epilepsy: "the truth is out there". Epilepsia 2004;45:1429-42. (Pubitemid 39470047)
3. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-85.
4. Grover S, Bala K, Sharma S, Gourie-Devi M, Baghel R, Kaur H, et al. Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients. Biochimie 2010;92:1207-12.
5. Leschziner G, Jorgensen AL, Andrew T, Pirmohamed M, Williamson PR, Marson AG, et al. Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: A prospective cohort study. Lancet Neurol 2006;5:668-76. (Pubitemid 44062410)
6. Ebid AH, Ahmed MM, Mohammed SA. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: A gene polymorphism perspective study. Ther Drug Monit 2007;29:305-12. (Pubitemid 47262260)
7. Schmidt D. Drug treatment of epilepsy: Options and limitations. Epilepsy Behav 2009;15:56-65.
8. Gottesman II, Gould TD. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 2003;160:636-45. (Pubitemid 41079594)
9. Szoeke CE, Newton M, Wood JM, Goldstein D, Berkovic SF, OBrien TJ, et al. Update on pharmacogenetics in epilepsy: A brief review. Lancet Neurol 2006;5:189-96. (Pubitemid 43107854)
10. Grover S, Gourie-Devi M, Baghel R, Sharma S, Bala K, Gupta M et al. Genetic profile of patients with epilepsy, on first line antiepileptic drugs and potential directions for personalized treatment. Pharmacogenomics 2010;11(7), 927-941.
11. Kitsios GD, Zintzaras E. Genome-wide association studies: Hypothesis-"free" or "engaged"? Transl Res 2009;154:161-4.
12. Wang Z, Wang J, Chong SS, Lee CGL. Mining Potential Functionally Significant Polymorphisms at the ATP Binding-Cassette Transporter Genes. Curr Pharmacogenomics Person Med 2009;7:40-58.
13. Pruitt KD, Harrow J, Harte RA, Wallin C, Diekhans M, Maglott DR, et al. The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. Genome Res 2009;19:1316-23.
14. Tan NC, Berkovic SF. The Epilepsy Genetic Association Database (epiGAD): Aanalysis of 165 genetic association studies, 1996-2008. Epilepsia 2010;51:686-9.
15. Li M, Li C. Assessing departure from Hardy-Weinberg equilibrium in the presence of disease association. Genet Epidemiol 2008;32:589-99.
16. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999;65:220-8. (Pubitemid 30470467)
17. Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, Kubo M, et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: Effects on population-based association studies. Am J Hum Genet 2008;83:445-56.
18. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-50. (Pubitemid 36150192)
19. Eberle MA, Rieder MJ, Kruglyak L, Nickerson DA. Allele frequency matching between SNPs reveals an excess of linkage disequilibrium in genic regions of the human genome. PLoS Genet 2006;2:e142.
20. Gupta M, Bhatnagar P, Grover S, Kaur H, Baghel R, Bhasin Y et al. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Pharmacogenomics 2009;10:385-97.
21. Briollais L, Wang Y, Rajendram I, Onay V, Shi E, Knight J, et al. Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: A population-based study in Ontario. BMC Med 2007;5:22.
22. Cabin RJ, Mitchell RJ. Bonferroni or not to Bonferroni: When and how are the questions. ESA Bull 2000;81:246-8.
23. Nicodemus KK, Liu W, Chase GA, Tsai YY, Fallin MD. Comparison of type I error for multiple test corrections in large single-nucleotide polymorphism studies using principal components versus haplotype blocking algorithms. BMC Genet 2005;6:S78.
24. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007;15:525-8. (Pubitemid 46175758)
25. Ufer M, Mosyagin I, Muhle H, Jacobsen T, Haenisch S, Häsler R, et al. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy. Pharmacogenet Genomics 2009;19:353-62.